Activating a molecular target reverses multiple hallmarks of aging, new study demonstrates
Small molecule restores TERT levels, reversing hallmarks of aging A high-throughput screen of over 650,000 compounds ...
Rznomics Inc.: Rznomics announces to secure the Expanded Access Program for patients with Glioblastoma (GBM)
Rznomics, Inc. announced to secure its expanded access program (EAP) from the United States Food and Drug Administration (FDA) for RZ-001 ...